Welltower has recently received positive analyst attention, with Scotiabank raising its price target to $166, maintaining an Outperform rating. The company's strategic acquisition of a C$4.6 billion Seniors Housing portfolio highlights its ability to secure high-quality assets, positioning it for growth in the seniors housing market. Additionally, Welltower's rebranding and focus on data-driven operations underscore its commitment to innovation and long-term growth.
The stock is currently trading at $149, with key technical indicators suggesting a neutral to bullish outlook. The MACD is positive at 3.56, indicating upward momentum, while the RSI of 51.09 suggests the stock is not overbought. Fibonacci levels indicate a pivot point at $152.26, with resistance at $156.97 and support at $147.55.
Based on the positive analyst sentiment and technical indicators, Welltower's stock is expected to reach $156.97 in the next trading week. The bullish MACD and Fibonacci resistance levels suggest a potential upside.
Recommendation: Buy WELL with a target price of $156.97.
The price of WELL is predicted to go up 6.91%, based on the high correlation periods with AMZN. The similarity of these two price pattern on the periods is 98.01%.
WELL
AMZN
The firm's intense focus on tenant and operator partnerships produces new off-market investment opportunities, benefiting shareholders. It should see same-store NOI growth above its peers in the senior housing sector due to its operational expertise and the strength of these relationships.
Welltower's diverse strategy allows it to consider a range of opportunities across property types and business models as a means for growth.
Welltower enjoys industry tailwinds, including an aging population and regulatory changes that expand the pool of participants in the healthcare system.
Wells Fargo
2025-03-10
Price Target
$140 → $158
Upside
+8.07%
Scotiabank
2025-03-06
Price Target
$165 → $166
Upside
+11.43%
Wedbush
2025-02-14
Price Target
$145 → $167
Upside
+11.36%